Photodynamic therapy: Applications in dermatology

Expert Opinion on Biological Therapy

Volumn 2, Issue 1, 2002, Pages 45-53

  Leman, J A ^a   Morton, C A ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Aminolaevulinic acid; Cutaneous malignancy; Photodynamic therapy

Indexed keywords

ALADERM; AMINOLEVULINIC ACID; BENZODIAZEPINE DERIVATIVE; HEMATOPORPHYRIN DERIVATIVE; LIDOCAINE; MERVIX; OXYGEN; PHOTOFRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT; PORPHIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; TETRAPHENYLPORPHINESULFONIC ACID;

BASAL CELL CARCINOMA; BOWEN DISEASE; DERMATOLOGY; DRUG FORMULATION; HUMAN; LASER; LIGHT; PHOTODYNAMICS; PHOTOSENSITIVITY; PHOTOTHERAPY; RADIATION DOSE; REVIEW; SKIN ABSORPTION; SKIN CANCER; SKIN INFLAMMATION; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRAVIOLET RADIATION; ANIMAL; FLUORESCENCE; PHOTOCHEMOTHERAPY; SKIN DISEASE;

ANIMALS; FLUORESCENCE; HUMANS; LIGHT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN DISEASES;

EID: 0035989689     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2.1.45     Document Type: Review

References (86)

1. Uber die wirkung fluoreszierenden stuffe auf infusoria
2. Theropeutische roesuche mit fluieszerenden stoff
3. Photoradiation therapy for the treatment of malignant tumours
4. 14C haematoporphyrin derivative distribution in normal and malignant tissue
5. Modified porphyrins, chlorins, phthalocyanins and purpurins: Second generation photosensitisers for photodynamic therapy
6. Photodynamic therapy by topical mesotetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinomas
7. Photodynamic therapy with mestetra(hydroxyphenyl)chlorin in the topical treatment of Bowen's disease and basal cell carcinoma
8. A dose-finding study of photodynamic therapy (PDT) with Metvix® in actinic keratoses (AK)
9. A dose finding study of photodynamic therapy (PDT) with Metvix® in patients with basal cell carcinoma (BCC)
10. Laser systems for photodynamic therapy
11. Photodynamic therapy in the management of cancer; an analysis of 114 cases
12. Photodynamic therapy for multiple skin cancers
13. Photodynamic therapy for the treatment of malignant cutaneous lesions
14. Use of photodynamic therapy for the treatment of extensive basal cell carcinomas
15. Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck
16. Photodynamic therapy for non melanoma skin cancer
17. Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms
18. Photodynamic therapy in head and neck surgery
19. Photodynamic therapy: A better treatment for widespread Bowen's disease
20. Photodynamic therapy in the treatment of Bowens disease
21. Prevalence of solar damage and actinic keratoses in a Merseyside population
22. Actinic keratoses
23. Photodynamic therapy with endogenous proporphyrin IX: Basic principles and clinical experience
24. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolaevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas and basal cell carcinomas?
25. Repetitive Photodynamic therapy with topical delta aminolaevulinic acid as an appropriate approach to the routine treatment of superficial nonmelanoma tumours
26. Photodynamic therapy with topical application of 5-aminolaevulinic acid in the treatment of actinic keraotoses: An initial clinical study
27. Photodynamic therapy of actinic keratoses with topical 5-aminolaecvulinic acid. A pilot dose ranging study
28. A randomised paired comparison of photodynamic therapy and topical 5-flurouracil in the treatment of actinic keratoses
29. Long-pulse dye laser for photodynamic therapy
30. A comparison of photodynamic therapy with topical 5-fluorouracil in the treatment of actinic keratoses
31. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses
32. Topical arninolaevulinic acid HCI photodynamic therapy
33. In vivo florescence kinetics and photodynamic therapy efficacy of delta-aminolaevulinic acid-induced porphyrins in basal cell carcinomaas and actinic keratoses; implications for optimisation of photodynamic therapy
34. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer
35. Photodynamic therapy of non-melanoma tumours of the skin using topical d-aminolevulinic acid sensitisation and laser irradiation
36. Development of an alternative light source to lasers for photodynamic therapy; Clinical evaluation in the treatment of nonmelanoma skin cancer
37. Comparison of photodynamic therapy with 5-Fluorouracil in Bowens disease
38. Comparison of photodynamic therapy with crotherapy in the treatment of Bowen's disease
39. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy
40. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma
41. Long-term follow up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy
42. Photodynamic therapy in dermatology
43. Photodynamic therapy for basal cell carcinoma: Effect of tumour thickness and duration of photosensitiser application on response
44. Topical photodynamic therapy at low fluence rates- theory and practice
45. Photodynamic therapy of epithelial skin tumours using delta aminolaevulinic acid and desferrioxamine
46. Photodynamic therapy of human skin tumours using topical application of 5-aminolaevulinic acid, DMSO and EDTA
47. Photodynamic therapy with 5-aminolaevulinic acid induced porphytins and skin penetration enhancer for basal cell carcinoma
48. Photodynamic therapy with delta-amonlaevulinic acid for nodular basal cell carcinomas using a prior debulking technique
49. Photodynamic therapy by topical aminolaevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma; a one year follow up study
50. Routine double treatment of superficial basal cell carcinomas using aminolaevulinic acid - Based photodynamic therapy
51. Photodynamic therapy vs cryosurgery of basal cell carcinomas; results of a phase III clinical trial
52. 5-ALA based photodynamic therapy
53. Treatment of superficial basal cell carcinomas with topical photodynamic therapy; recurrence rates and outcome
54. Guidelines for the management of basal cell carcinoma
55. Verrucas: Guidelines for management
56. Topical photodynamic therapy in verrucae. A pilot study
57. Treatment of recalcitrant verrucae by photosensitivity with topical application of delta aminolaevulinic acid
58. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid; a pilot study
59. Photodynamic therapy of recalcitrant warts with 5-aminolaevulinic acid: A retrospective analysis
60. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts; randomised double-blind trial
61. Phototherapy with blue (415nm) and red (660nm) light in the treatment of acne vulgaris
62. Topical ALA-Photodynamic therapy for the treatment for acne vulgaris
63. Photodynamic therapy of acne vulgaris with topical 5-aminolaevulinic acid
64. Photodynamic therapy of acne vulgaris with topical 5-aminolaevulinic acid and incoherent light in Japanese patients
65. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy
66. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolaevulinic acid indicates a potential for superficial photodynamic therapy
67. Photodynamic therapy (PDT) of psoriasis with topical delta aminolaevulininc acid (ALA); a pilot dose ranging study
68. Treatment of psoriasis by topical photodynamic therapy with polychromatic light
69. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy
70. Photodynamic therapy for mycosis fungoides after topical photosensitisation with 5-aminolevulinic acid
71. Photodynamic therapy for mycosis fungoides after topical sensitization with 5-aminolevulinic acid
72. The treatment of cutaneous T cell lymphoma by topical aminolaevulinic acid photodynamic therapy
73. Topical 5-aminolevulinic acid based photodynamic therapy for mycosis fungoides - A study of cell proliferation and apoptosis before and after therapy
74. Photodynamic therapy utilizing topical daminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin
75. Photodynamic therapy of cutaneous T cell lymphoma at special sites
76. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application
77. Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides
78. Photodynamic therapy with 5-aminolaevulinic acid in the treatment of actinic cheilitis
79. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolaevulinic acid
80. Topical photodynamic therapy for localised scleroderma
81. Photodynamic therapy for condylomata acuminata with local application of 5-aminolaevulinic acid
82. PDT for hirsutism
83. Edidermodysplasia veruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy
84. Photodynamic therapy for nevus sebaceous with topical delta-aminolaevulinic acid
85. Treatment of lichen planus of the penis with phorodynamic therapy
86. Topical Photodynamic therapy with 5-aminolaevulinic acid does not induce regrowth in patients with extensive alopecia